UroGen Pharma Ltd. (NASDAQ:URGN) Q2 2024 Earnings Call Transcript August 13, 2024
UroGen Pharma Ltd. misses on earnings expectations. Reported EPS is $-0.91 EPS, expectations were $-0.82.
Operator: Good day and thank you for standing by. Welcome to the 2024 Second Quarter UroGen Pharma Earnings Call. [Operator Instructions] Please advise that today’s conference is being recorded. I would now like to hand the conference over to your first speaker today, Vincent Perrone, Head of Investor...
